4//SEC Filing
Pamir Ozan 4
Accession 0001213900-23-074485
CIK 0001690080other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 6:30 PM ET
Size
6.5 KB
Accession
0001213900-23-074485
Insider Transaction Report
Form 4
Pamir Ozan
Interim CFO
Transactions
- Award
Stock Option (Right to Buy)
2023-09-04+15,000→ 15,000 totalExercise: $0.67Exp: 2033-09-04→ Common Stock (15,000 underlying)
Holdings
- 8,983.077
Common Stock
Footnotes (2)
- [F1]The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Financial Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
- [F2]The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001834681
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 6:30 PM ET
- Size
- 6.5 KB